Why Are Women in Canada Waiting So Long for Menopause-Related Care?

When hot flashes, insomnia, brain fog, mood swings, and irregular periods begin, many women in Canada do not enter a clear treatment pathway right away. The experience often starts with uncertainty: is it stress, exhaustion, anxiety, or simply aging? That confusion is not a small detail. According to an Ipsos survey commissioned by GreenShield and published in March 2026, 33 per cent of women said they waited more than two years to receive effective menopause-related care, while 32 per cent of women who had experienced symptoms linked to this stage said they had never received a formal diagnosis.

The first reason for that delay is that menopause is still treated in Canada as a health issue clouded by silence and limited understanding. The Menopause Foundation of Canada’s “Menopause in Canada” report found that 54 per cent of women still see the subject as taboo, while 46 per cent feel unprepared for this stage of life. In the newer survey, 29 per cent of women said they believed their symptoms were normal and not treatable, 26 per cent said they did not recognize the symptoms as part of a hormonal transition, 39 per cent said they did not know where to go for help, and 21 per cent said their concerns had been dismissed. When limited knowledge meets hesitation, silence, and minimization, long delays become almost predictable.

The second reason is that the healthcare system itself often fails to catch women early enough. In October 2025, Ontario Health released Canada’s first quality standard for perimenopause and menopause care. It says clinicians should ask women about menopause-associated symptoms starting at age 40, and that primary care should handle assessment and treatment, with referral to a menopause specialist only when clinically indicated. But that vision collides with a harder reality: the Ontario Medical Association said in December 2025 that more than 2.5 million people in the province do not have access to a family physician. When the main entry point to care is missing or overloaded, waiting becomes longer.

The third reason is that access to treatment remains uneven across provinces and between women who can afford to look elsewhere and those who cannot. The Menopause Foundation of Canada says virtual and private menopause clinics are growing across the country because they have become an option for people who do not have a family doctor or cannot find a provider trained in menopause care. Drug coverage also differs by province. Manitoba has provided no-cost coverage for most hormone replacement therapy medications for eligible residents since April 15, 2025, while British Columbia has covered menopausal hormone therapy under Plan NP since March 1, 2026. That means a woman’s experience with menopause care can vary significantly depending on where she lives and what kind of coverage she can access.

The issue, then, is not that menopause is mysterious or without treatment options. Ontario’s quality standard itself says menopausal hormone therapy should be offered as a first-line treatment for vasomotor symptoms after weighing risks and benefits, and that women experiencing other symptoms, including those related to sleep, mood, cognition, or genitourinary health, should also be offered evidence-based treatment options. The central problem is that recognition has been too slow, the care pathway remains confusing, and the system has not treated this stage of women’s health with the urgency it requires